Access Pharmaceuticals Featured on Onclive.Com
ACCESS PHARMACEUTICALS, INC., a developer of new products for oncology supportive care, announced that its novel product for oral mucositis, MuGard®, has been featured in an article on OncLive.com titled, “Study Finds Mouth Rinse Alleviates Oral Mucositis Symptoms in Head and Neck Cancers.” Dr. Steve Sonis, a leading expert in oral mucositis, provides insight on the growing demand seen in the oncology community for evidence-based strategies for the debilitating anticancer regimen side effect.
View full press release